Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the biopharmaceutical industry. This time, you get to discover 5 hand-picked cloud computing startups impacting biopharma.
Out of 130, the Global Startup Heat Map highlights 5 Top Cloud Computing Startups impacting Biopharma
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering 2 093 000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 130 exemplary startups & scaleups we analyzed for this research. Further, it highlights 5 biopharmaceutical startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these 5 startups & scaleups in this report. For insights on the other 125 cloud computing startups for biopharma, get in touch.
Click to download
Rosa Biotech provides a Biosensing Platform
Founding Year: 2019
Location: Bristol, UK
Funding: USD 1 M
Partner with Rosa Biotech for ML-based Diagnostics
British startup Rosa Biotech provides Pandra, a biosensing platform. Pandra recognizes patterns of displacement from a cloud database that contains sample data for the determination of analyte characteristics. The platform’s peptide arrays detect various small molecule biomarkers of disease in patient samples, creating a fluorescence fingerprint for each detection. Therefore, developing new sensors only requires annotated samples to screen the peptide library and train models, enabling biopharmaceutical companies to speed up drug development.
Empirico enables Therapeutic Target Discovery
Founding Year: 2017
Location: San Diego, US
Funding: USD 13 M
Use this solution for Translationational Clinical Development
Empirico is a US-based startup that advances therapeutic target discovery and development. The startup’s cloud-based platform, Precision Insights Platform, facilitates therapeutic discovery by leveraging biological datasets and advanced algorithms. The platform experimentally validates therapeutic targets in-house prior to progressing through preclinical development. This allows biopharma companies to better understand the role of genes and proteins in health and disease while identifying therapeutic targets with a high probability of translational success.
ELEM Biotech offers Biomedical Simulations
Founding Year: 2018
Location: Barcelona, Spain
Funding: USD 13 600
Innovate with the startup to build 3D Simulation Models
Spanish startup ELEM Biotech provides biomedical simulations. The startup builds virtual cardiovascular and respiratory systems that incorporate electrical activities, mechanical deformation, and fluid mechanics. Such replications of human cells, tissues, and organs allow biomedical businesses to predict the efficiency of treatments and medicines in restoring bodily functions. The startup’s surrogate system also enables virtual patient trials as well as facilitates treatment innovation and development.
Geneyx enables Rare Disorder Diagnosis
Founding Year: 2018
Location: Pennsylvania, US
Funding: USD 8,2 M
Partner with Geneyx for Clinical Risk Prediction
Geneyx is a US-based startup that offers a cloud-based solution for rare and germline disorders. The startup’s AI-based analytics platform utilizes diverse databases to interpret whole-genome sequencing (WGS) data, whole-exome sequencing (WES) data, and gene panels. The analysis enables rapid assignment of variant classifications and scoring with detailed evidence, including case-level contextual information with inheritance models and associated samples. This provides disease-specific, clinically relevant insights on risk prediction, diagnosis, prognosis, and treatment for biopharmaceutical organizations.
ATGENOMIX facilitates Genomics Data Processing
Founding Year: 2017
Location: Taipei, Taiwan
Funding: USD 11 M
Collaborate with the startup to Accelerate Bioinformatics Pipelines
Taiwanese startup ATGENOMIX provides a cloud-based genomics data processing platform. The startup enables data parallelization using advanced computing technologies, accelerating bioinformatics pipelines. The platform provides an integrated interface to annotate the genetic variants derived from a large number of personal genomes based on curated databases. It estimates the effects of these variants by incorporating several parallel algorithms, allowing biopharma companies to speed up the process of variant annotation and interpretation.
Discover more Biopharma Startups
Startups such as the examples highlighted in this report focus on bioinformatics, target discovery, disease diagnosis as well as artificial intelligence and machine learning. While all of these technologies play a major role in advancing the biopharmaceutical sector, they only represent the tip of the iceberg. To explore more biopharma solutions, simply get in touch to let us look into your areas of interest. For a more general overview, you can download one of our free Industry Innovation Reports to save your time and improve strategic decision-making.
